CRANE NXT, CO.
In the published model solve dated 2026-Q2, anchored at $50.06, CRANE NXT, CO. (CXT) is priced for +5.0% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Crane NXT is two businesses of almost equal size: payment and currency-handling equipment on one side, and banknote production plus authentication technology on the other, and the annual report warns that the second half is ⟦subject to significant variability due to the timing and size of contract awards by central banks for banknote production and actual order rates, particularly with the U.S. government⟧. • The cost of the recent buying shows up immediately in the March 2026 quarter, where
Is CXT overvalued? See what's priced in →
339 institutional managers reported holding CXT in 13F filings for the quarter ended 2026-03-31. Together they hold about 94% of the company; the top 10 hold 52%. 48 opened new positions that quarter. Held by FMR (Fidelity), Vanguard Group, BlackRock, among others. On the short side, 7.5M shares were sold short as of the 2026-06-15 count, about 13% of shares outstanding (7.5 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CXT has cut its share count 65.9% over the past five years, spending $300.00M on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting), raised 2 years straight; the current rate is $0.68 a share annually. Cash returned over the past three years: $101.70M in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at CXT over the trailing three years: 2023: 1 buy totaling $60k; 2025: 1 buy totaling $1k; 2026: 2 buys totaling $1.16M. 9 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CXT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-08 | +10.4% | -12.1% |
| 2023-11-07 | -8.3% | +9.3% |
| 2024-02-23 | +0.3% | +3.4% |
| 2024-05-09 | -3.6% | -5.9% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CXT's latest 8-K filings: 2026-08-11 (items 7.01); 2026-08-05 (items 2.02, 9.01); 2026-05-28 (items 5.07, 9.01); 2026-05-06 (items 2.02, 9.01); 2026-03-12 (items 5.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.